Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis

Adimadhyam, S; Lewis, JD; Simon, AL; Wolfe, AE; Smith, S; Hou, L; Moyneur, E; Reynolds, JS; Toh, S; Dobes, A; Parlett, L; Haynes, K; Burris, J; Dorand, JE; Long, MD; Kappelman, MD

Kappelman, MD (通讯作者)，Univ North Carolina Chapel Hill, Campus Box 7229,Bioinformat Bldg,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.

INFLAMMATORY BOWEL DISEASES, 2023; ():

Abstract

Background Antitumor necrosis factor (anti-TNF) inhibitors are first-line treatment among patients with ulcerative colitis (UC). With time, patients t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索